[1] Jin LY, Zhao CJ, Li HN, Wang RB, Wang Q, Wang H. Clinical profile, prognostic factors, and outcome prediction in hospitalized patients with bloodstream infection: results from a 10-year prospective multicenter study. Front Med 2021;8:629671. http://dx.doi.org/10.3389/fmed.2021.629671.
[2] Yin YY, Zhao CJ, Li HN, Jin LY, Wang Q, Wang RB, et al. Clinical and microbiological characteristics of adults with hospital-acquired pneumonia: a 10-year prospective observational study in China. Eur J Clin Microbiol Infect Dis 2021;40(4):683 − 90. http://dx.doi.org/10.1007/s10096-020-04046-9.
[3] China Antimicrobial Resistance Surveillance System. 2020 National antimicrobial resistance surveillance report. Chin J Lab Med 2022; 45(2):122-136. (In Chinese).
[4] Chen HB, Yin YY, van Dorp L, Shaw LP, Gao H, Acman M, et al. Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China. Genome Med 2021;13(1):171. http://dx.doi.org/10.1186/s13073-021-00992-x.
[5] Gao H, Liu YD, Wang RB, Wang Q, Jin LY, Wang H. The transferability and evolution of NDM-1 and KPC-2 co-producing Klebsiella pneumoniae from clinical settings. eBioMedicine 2020;51:102599. http://dx.doi.org/10.1016/j.ebiom.2019.102599.
[6] Zhang YW, Jin LY, Ouyang PW, Wang Q, Wang RB, Wang J, et al. Evolution of hypervirulence in carbapenem-resistant Klebsiella pneumoniae in China: a multicentre, molecular epidemiological analysis. J Antimicrob Chemother 2020;75(2):327 − 36. http://dx.doi.org/10.1093/jac/dkz446.
[7] Liu YY, Wang Y, Walsh TR, Yi LX, Zhang R, Spencer J, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016;16(2):161 − 8. http://dx.doi.org/10.1016/S1473-3099(15)00424-7.
[8] Sun SJ, Gao H, Liu YD, Jin LY, Wang RB, Wang XJ, et al. Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in Klebsiella pneumoniae. Emerg Microbes Infect 2020;9(1):1102 − 13. http://dx.doi.org/10.1080/22221751.2020.1768805.
[9] Zhang P, Shi Q, Hu H, Hong B, Wu X, Du X, et al. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China. Clin Microbiol Infect 2020;26(1):124.e1 − 4. http://dx.doi.org/10.1016/j.cmi.2019.08.020.
[10] Wang Q, Jin LY, Sun SJ, Yin YY, Wang RB, Chen FN, et al. Occurrence of high levels of cefiderocol resistance in carbapenem-resistant Escherichia coli before its approval in China: a report from China CRE-Network. Microbiol Spectr 2022;10(3):e0267021. http://dx.doi.org/10.1128/spectrum.02670-21.
[11] Han DS, Li ZY, Li R, Tan P, Zhang R, Li JM. mNGS in clinical microbiology laboratories: on the road to maturity. Crit Rev Microbiol 2019;45(5 − 6):668 − 85. http://dx.doi.org/10.1080/1040841X.2019.1681933.
[12] Zhang QQ, Ying GG, Pan CG, Liu YS, Zhao JL. Comprehensive evaluation of antibiotics emission and fate in the river basins of China: source analysis, multimedia modeling, and linkage to bacterial resistance. Environ Sci Technol 2015;49(11):6772 − 82. http://dx.doi.org/10.1021/acs.est.5b00729.
[13] Shen C, Zhong LL, Zhong ZJ, Doi Y, Shen JZ, Wang Y, et al. Prevalence of mcr-1 in colonized inpatients, China, 2011-2019. Emerg Infect Dis 2021;27(9):2502 − 4. http://dx.doi.org/10.3201/EID2709.203642.
[14] Sun J, Chen C, Cui CY, Zhang Y, Liu X, Cui ZH, et al. Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. Nat Microbiol 2019;4(9):1457 − 64. http://dx.doi.org/10.1038/s41564-019-0496-4.
[15] Lang AS, Westbye AB, Beatty JT. The distribution, evolution, and roles of gene transfer agents in prokaryotic genetic exchange. Annu Rev Virol 2017;4:87 − 104. http://dx.doi.org/10.1146/annurev-virology-101416-041624.
[16] Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al. A new antibiotic kills pathogens without detectable resistance. Nature 2015;517(7535):455 − 9. http://dx.doi.org/10.1038/nature14098.
[17] Vekemans J, Hasso-Agopsowicz M, Kang G, Hausdorff WP, Fiore A, Tayler E, et al. Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: a World Health Organization Action Framework. Clin Infect Dis 2021;73(4):e1011 − 17. http://dx.doi.org/10.1093/cid/ciab062.
[18] Zeng H, Zhang JY, Song X, Zeng JM, Yuan Y, Chen ZF, et al. An immunodominant epitope-specific monoclonal antibody cocktail improves survival in a mouse model of Staphylococcus aureus bacteremia. J Infect Dis 2021;223(10):1743 − 52. http://dx.doi.org/10.1093/infdis/jiaa602.